Current
$210B
5-Year Average
$151B
All-Time High
$214B
All-Time Low
$33.7B
Market cap daily chart for Amgen (AMGN)
Aug 2, 2021 – Jul 31, 2026 · 1,255 trading days
Market Cap growth chart for Amgen (AMGN) from 2017 to 2026
Latest: +18.1%
Market Cap history table for Amgen (AMGN) from 1985 to 2026
| 2026 | $210B | +18.1% | +$32.1B | ||
| 2025 | $177B | +25.8% | +$36.4B | ||
| 2024 | $141B | -9.0% | -$13.9B | ||
| 2023 | $155B | +9.1% | +$12.9B | ||
| 2022 | $142B | +10.2% | +$13.2B | ||
| 2021 | $129B | -5.0% | -$6.74B | ||
| 2020 | $136B | -7.6% | -$11.2B | ||
| 2019 | $147B | +13.4% | +$17.4B | ||
| 2018 | $129B | +1.3% | +$1.64B | ||
| 2017 | $128B | +15.9% | +$17.6B | ||
| 2016 | $110B | -11.3% | -$14.1B | ||
| 2015 | $124B | +1.4% | +$1.69B | ||
| 2014 | $123B | +40.5% | +$35.4B | ||
| 2013 | $87.3B | +28.6% | +$19.4B | ||
| 2012 | $67.8B | +15.8% | +$9.28B | ||
| 2011 | $58.6B | +10.5% | +$5.58B | ||
| 2010 | $53B | -8.3% | -$4.78B | ||
| 2009 | $57.8B | -7.0% | -$4.32B | ||
| 2008 | $62.1B | +19.0% | +$9.93B | ||
| 2007 | $52.2B | -35.8% | -$29.1B | ||
| 2006 | $81.3B | -18.1% | -$17.9B | ||
| 2005 | $99.2B | +17.2% | +$14.5B | ||
| 2004 | $84.7B | +1.8% | +$1.51B | ||
| 2003 | $83.2B | +49.2% | +$27.4B | ||
| 2002 | $55.8B | -8.9% | -$5.44B | ||
| 2001 | $61.2B | -11.8% | -$8.15B | ||
| 2000 | $69.4B | +7.1% | +$4.59B | ||
| 1999 | $64.8B | +134.3% | +$37.1B | ||
| 1998 | $27.6B | +86.0% | +$12.8B | ||
| 1997 | $14.9B | -2.7% | -$408M | ||
| 1996 | $15.3B | -9.8% | -$1.67B | ||
| 1995 | $16.9B | +103.3% | +$8.6B | ||
| 1994 | $8.33B | +22.9% | +$1.55B | ||
| 1993 | $6.78B | -33.4% | -$3.41B | ||
| 1992 | $10.2B | -1.1% | -$115M | ||
| 1991 | $10.3B | +524.7% | +$8.65B | ||
| 1990 | $1.65B | — | — | ||
| 1988 | $577M | -5.1% | -$31.1M | ||
| 1987 | $608M | +40.1% | +$174M | ||
| 1986 | $434M | +165.4% | +$270M | ||
| 1985 | $163M | — | — |
- 2026$210B+18.1%
- 2025$177B+25.8%
- 2024$141B-9.0%
- 2023$155B+9.1%
- 2022$142B+10.2%
- 2021$129B-5.0%
- 2020$136B-7.6%
- 2019$147B+13.4%
- 2018$129B+1.3%
- 2017$128B+15.9%
- 2016$110B-11.3%
- 2015$124B+1.4%
- 2014$123B+40.5%
- 2013$87.3B+28.6%
- 2012$67.8B+15.8%
- 2011$58.6B+10.5%
- 2010$53B-8.3%
- 2009$57.8B-7.0%
- 2008$62.1B+19.0%
- 2007$52.2B-35.8%
- 2006$81.3B-18.1%
- 2005$99.2B+17.2%
- 2004$84.7B+1.8%
- 2003$83.2B+49.2%
- 2002$55.8B-8.9%
- 2001$61.2B-11.8%
- 2000$69.4B+7.1%
- 1999$64.8B+134.3%
- 1998$27.6B+86.0%
- 1997$14.9B-2.7%
- 1996$15.3B-9.8%
- 1995$16.9B+103.3%
- 1994$8.33B+22.9%
- 1993$6.78B-33.4%
- 1992$10.2B-1.1%
- 1991$10.3B+524.7%
- 1990$1.65B—
- 1988$577M-5.1%
- 1987$608M+40.1%
- 1986$434M+165.4%
- 1985$163M—
Market Cap values are taken from Amgen's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported market cap is $191B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Amgen (AMGN) came in at $210B – grew 18.1% year-over-year.
Through 2021–2026 (5 years), Amgen market cap delivered a +10.2% annualised rate; sustaining 2 straight years of year-over-year growth.
Across the available history, market cap reached its high of $210B in 2026 and its low of $163M in 1985.
Amgen Market Cap by Year
Amgen Market Cap 2026: $210B
2026's market cap for Amgen came in at $210B, grew 18.1% from 2025. This figure represents the highest annual value in the available history.
Amgen Market Cap 2025: $177B
Amgen posted market cap of $177B in 2025, grew 25.8% from 2024.
Amgen Market Cap 2024: $141B
In 2024, Amgen reported market cap of $141B, declined 9.0% below 2023.
Amgen Market Cap 2023: $155B
Amgen market cap in 2023 was $155B, grew 9.1% from 2022.
Amgen Market Cap 2022: $142B
Amgen market cap in 2022 was $142B.
See more financial history for Amgen (AMGN).
Sector peers by Market Cap
Healthcare peers of Amgen (AMGN), ranked by their latest market cap
Frequently asked questions
Test yourself on AMGN
Market Cap — 10 rounds, every one of them AMGN against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile2.54% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.